Exact Mass: 487.063
Exact Mass Matches: 487.063
Found 38 metabolites which its exact mass value is equals to given mass value 487.063,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
CAY10575
5-(5,6-dimethoxy-1H-benzimidazol-1-yl)-3-[[4-(methylsulfonyl)phenyl]methoxy]-2-thiophenecarboxamide
(3R)-3-Amino-4-(2,5-difluorophenyl)-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-butanone phosphate (1:1)
(3R)-3-Amino-4-(2,5-difluorophenyl)-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-butanone phosphate (1:1)
5,7-dichloro-2-trityl-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid
5,7-dichloro-2-trityl-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid
2-(4-bromophenyl)-4,6-di(naphthalen-2-yl)-1,3,5-triazine
2-(4-bromophenyl)-4,6-di(naphthalen-2-yl)-1,3,5-triazine
ethyl 5-(benzyloxy)-6-broMo-2-(3-ethoxy-3-oxopropyl)-1-Methyl-1H-indole-3-carboxylate
ethyl 5-(benzyloxy)-6-broMo-2-(3-ethoxy-3-oxopropyl)-1-Methyl-1H-indole-3-carboxylate
2-O-benzyl 1-O-tert-butyl (2S,4R)-4-[(4-bromophenyl)methyl]-5-oxopyrrolidine-1,2-dicarboxylate
2-O-benzyl 1-O-tert-butyl (2S,4R)-4-[(4-bromophenyl)methyl]-5-oxopyrrolidine-1,2-dicarboxylate
Fulacimstat
Fulacimstat
C78274 - Agent Affecting Cardiovascular System D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor
cytidine diphosphate choline
cytidine diphosphate choline
N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics D002491 - Central Nervous System Agents > D018697 - Nootropic Agents COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
6-bromo-3-[4-oxo-4-[4-(2-pyridinyl)-1-piperazinyl]butyl]-2-sulfanylidene-1H-quinazolin-4-one
6-bromo-3-[4-oxo-4-[4-(2-pyridinyl)-1-piperazinyl]butyl]-2-sulfanylidene-1H-quinazolin-4-one
5-(5,6-dimethoxy-1H-benzimidazol-1-yl)-3-[[4-(methylsulfonyl)phenyl]methoxy]-2-thiophenecarboxamide
5-(5,6-dimethoxy-1H-benzimidazol-1-yl)-3-[[4-(methylsulfonyl)phenyl]methoxy]-2-thiophenecarboxamide
2-[[5-cyano-7-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidin-4-yl]amino]butanedioic acid
2-[[5-cyano-7-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidin-4-yl]amino]butanedioic acid
Benzenesulfonamide, 4-iodo-N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-
Benzenesulfonamide, 4-iodo-N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-
2-pyridin-4-yl-N-[4-(2-thiazolylsulfamoyl)phenyl]-4-quinolinecarboxamide
2-pyridin-4-yl-N-[4-(2-thiazolylsulfamoyl)phenyl]-4-quinolinecarboxamide
2-[[1-[(3-bromophenyl)methyl]-3-indolyl]sulfonyl]-N-(5-methyl-3-isoxazolyl)acetamide
2-[[1-[(3-bromophenyl)methyl]-3-indolyl]sulfonyl]-N-(5-methyl-3-isoxazolyl)acetamide
N-[3-[(3-chlorophenyl)sulfamoyl]-4-methylphenyl]-3-(4-nitrophenyl)-3-oxopropanamide
N-[3-[(3-chlorophenyl)sulfamoyl]-4-methylphenyl]-3-(4-nitrophenyl)-3-oxopropanamide
(E)-3-(4-fluorophenyl)-N-[[4-[(3-methoxypyrazin-2-yl)sulfamoyl]phenyl]carbamothioyl]prop-2-enamide
(E)-3-(4-fluorophenyl)-N-[[4-[(3-methoxypyrazin-2-yl)sulfamoyl]phenyl]carbamothioyl]prop-2-enamide
5-Acetyl-2-[2-(6-fluoro-9H-1,3,4,9-tetraaza-fluoren-2-ylsulfanyl)-acetylamino]-4-methyl-thiophene-3-carboxylic acid ethyl ester
5-Acetyl-2-[2-(6-fluoro-9H-1,3,4,9-tetraaza-fluoren-2-ylsulfanyl)-acetylamino]-4-methyl-thiophene-3-carboxylic acid ethyl ester
4,7-DI(Para-ethoxyphenyl)-6-(ortho-chlorophenyl)-1,2,5-thiadiazolo(3,4-C)pyridine
4,7-DI(Para-ethoxyphenyl)-6-(ortho-chlorophenyl)-1,2,5-thiadiazolo(3,4-C)pyridine
CDP-choline(1-)
CDP-choline(1-)
Conjugate base of CDP-choline(1+) arising from deprotonation of the diphosphate function.
SB 271046 (Hydrochloride)
SB 271046 (Hydrochloride)
SB 271046 Hydrochloride (SB 271046A) is a potent, selective and orally active 5-HT6 receptor antagonist with pKi of 9.02, 8.55, and 8.81 for rat, pig and human, respectively. SB 271046 Hydrochloride is over 200 fold selective for the 5-HT6 receptor vs 55 other receptors, binding sites and ion channels. Anticonvulsant activity (EC50=0.16 μM)[1].
(1s,2s,5s,8s)-5-[(4s)-2-(1-hydroxy-4-methoxynaphthalen-2-yl)-4,5-dihydro-1,3-thiazol-4-yl]-8,11-dimethyl-4,10-dithia-6,11-diazatricyclo[6.2.1.0²,⁶]undecan-7-one
(1s,2s,5s,8s)-5-[(4s)-2-(1-hydroxy-4-methoxynaphthalen-2-yl)-4,5-dihydro-1,3-thiazol-4-yl]-8,11-dimethyl-4,10-dithia-6,11-diazatricyclo[6.2.1.0²,⁶]undecan-7-one
4,4-dichloro-n-{5,5-dichloro-4-methyl-1-oxo-1-[2-(1,3-thiazol-2-yl)pyrrolidin-1-yl]pentan-2-yl}-3-methylbutanimidic acid
4,4-dichloro-n-{5,5-dichloro-4-methyl-1-oxo-1-[2-(1,3-thiazol-2-yl)pyrrolidin-1-yl]pentan-2-yl}-3-methylbutanimidic acid
(3s,4s)-8-[(1r)-2-amino-1-hydroxyethyl]-4-(3-bromo-4-hydroxyphenyl)-3-(3-hydroxyphenoxy)-3,4-dihydro-2h-1-benzopyran-5-ol
(3s,4s)-8-[(1r)-2-amino-1-hydroxyethyl]-4-(3-bromo-4-hydroxyphenyl)-3-(3-hydroxyphenoxy)-3,4-dihydro-2h-1-benzopyran-5-ol
8-(2-amino-1-hydroxyethyl)-4-(3-bromo-4-hydroxyphenyl)-3-(3-hydroxyphenoxy)-3,4-dihydro-2h-1-benzopyran-5-ol
8-(2-amino-1-hydroxyethyl)-4-(3-bromo-4-hydroxyphenyl)-3-(3-hydroxyphenoxy)-3,4-dihydro-2h-1-benzopyran-5-ol
5-[2-(1-hydroxy-4-methoxynaphthalen-2-yl)-4,5-dihydro-1,3-thiazol-4-yl]-8,11-dimethyl-4,10-dithia-6,11-diazatricyclo[6.2.1.0²,⁶]undecan-7-one
5-[2-(1-hydroxy-4-methoxynaphthalen-2-yl)-4,5-dihydro-1,3-thiazol-4-yl]-8,11-dimethyl-4,10-dithia-6,11-diazatricyclo[6.2.1.0²,⁶]undecan-7-one
(3s,4r)-8-[(1r)-2-amino-1-hydroxyethyl]-4-(3-bromo-4-hydroxyphenyl)-3-(3-hydroxyphenoxy)-3,4-dihydro-2h-1-benzopyran-5-ol
(3s,4r)-8-[(1r)-2-amino-1-hydroxyethyl]-4-(3-bromo-4-hydroxyphenyl)-3-(3-hydroxyphenoxy)-3,4-dihydro-2h-1-benzopyran-5-ol
